APOE and Alzheimer disease: Contrary to findings in clinical FTD and AD [11, 13–16], differences in diffusion metrics associated with asymptomatic APOE4 [39, 44–51] are more widespread than diffusion differences associated with asymptomatic MAPT/GRN mutation carriers [32, 33].